Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

By B. Pitt, P. A. Poole-Wilson, R. Segal, F. Martinez, K. Dickstein, John Camm, Marvin A. Konstam, G. Riegger, George Klinger, J. Neaton and 2 more. The Lancet, 2000

1,989 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/1fc4d42bda5099d95caa6c3257675e190e6509e2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. T. Minamino
2. Masanori Sano
3. N. Makita
4. Weidong Zhu
5. T. Nagai
6. Yingjie Qin
7. K. Iwanaga
8. H. Takano

Citations in the corpus

• Renin‐angiotensin system revisited (2008, background): “In addition, ARBs which block Ang II actions irrespective of generating enzyme(s) have not proven superior to ACE inhibitors in large clinical trials [24, 25] .”
• Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II (2004, background): “Furthermore, many animal and clinical studies have shown that AT1 receptor blockers induce regression of cardiac hypertrophy and prevent progression of heart failure, resulting in a reduction in cardiac morbidity and mortalit”